Cargando…
Effect of screening for type 1 diabetes on early metabolic control: the DiPiS study
AIMS/HYPOTHESIS: It has been shown that children previously enrolled in follow-up studies have better glycaemic control during the early period after diabetes diagnosis. The aim of this study was to analyse glycaemic control over a longer period, past the period of partial remission, after diagnosis...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290658/ https://www.ncbi.nlm.nih.gov/pubmed/30109365 http://dx.doi.org/10.1007/s00125-018-4706-z |
_version_ | 1783380132630626304 |
---|---|
author | Lundgren, Markus Jonsdottir, Berglind Elding Larsson, Helena |
author_facet | Lundgren, Markus Jonsdottir, Berglind Elding Larsson, Helena |
author_sort | Lundgren, Markus |
collection | PubMed |
description | AIMS/HYPOTHESIS: It has been shown that children previously enrolled in follow-up studies have better glycaemic control during the early period after diabetes diagnosis. The aim of this study was to analyse glycaemic control over a longer period, past the period of partial remission, after diagnosis in children followed before diagnosis in the Swedish Diabetes Prediction in Skåne (DiPiS) study compared with children of equal age not enrolled in pre-diabetes follow-up, receiving equivalent diabetes care. METHODS: HbA(1c) from diagnosis and for the following 5 years, as well as differences in insulin dosage, BMI, pump use, partial remission according to insulin dose-adjusted HbA(1c) and baseline demographics were compared between children who were enrolled in follow-up and had received information on diabetes risk (n = 51) and children not enrolled in follow-up (n = 78). RESULTS: The group followed before diagnosis had a higher proportion of first-degree relatives (FDRs) with diabetes (28% vs 5.6%; p = 0.001) and a higher proportion of participants with mothers born in Sweden (100% vs 89%; p = 0.02). No significant differences in total daily insulin dose, pump use or other baseline sociodemographic factors were detected between the groups. Median HbA(1c) at diagnosis and at 1, 2, 3, 4 and 5 years after diabetes diagnosis was significantly lower in children followed before diagnosis (all p < 0.05), and was not related to FDR status. CONCLUSIONS/INTERPRETATION: Compared with controls not previously enrolled in follow-up, our study shows that children enrolled in longitudinal follow-up before the diagnosis of diabetes have better glycaemic control, measured by HbA(1c), up to 5 years after diagnosis and during the initial period of partial remission. Improved glycaemic control in the initial years of living with type 1 diabetes could affect long-term outcome and complications and might also improve study enrolment in future longitudinal studies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00125-018-4706-z) contains peer-reviewed but unedited supplementary material, which is available to authorised users. |
format | Online Article Text |
id | pubmed-6290658 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-62906582018-12-27 Effect of screening for type 1 diabetes on early metabolic control: the DiPiS study Lundgren, Markus Jonsdottir, Berglind Elding Larsson, Helena Diabetologia Short Communication AIMS/HYPOTHESIS: It has been shown that children previously enrolled in follow-up studies have better glycaemic control during the early period after diabetes diagnosis. The aim of this study was to analyse glycaemic control over a longer period, past the period of partial remission, after diagnosis in children followed before diagnosis in the Swedish Diabetes Prediction in Skåne (DiPiS) study compared with children of equal age not enrolled in pre-diabetes follow-up, receiving equivalent diabetes care. METHODS: HbA(1c) from diagnosis and for the following 5 years, as well as differences in insulin dosage, BMI, pump use, partial remission according to insulin dose-adjusted HbA(1c) and baseline demographics were compared between children who were enrolled in follow-up and had received information on diabetes risk (n = 51) and children not enrolled in follow-up (n = 78). RESULTS: The group followed before diagnosis had a higher proportion of first-degree relatives (FDRs) with diabetes (28% vs 5.6%; p = 0.001) and a higher proportion of participants with mothers born in Sweden (100% vs 89%; p = 0.02). No significant differences in total daily insulin dose, pump use or other baseline sociodemographic factors were detected between the groups. Median HbA(1c) at diagnosis and at 1, 2, 3, 4 and 5 years after diabetes diagnosis was significantly lower in children followed before diagnosis (all p < 0.05), and was not related to FDR status. CONCLUSIONS/INTERPRETATION: Compared with controls not previously enrolled in follow-up, our study shows that children enrolled in longitudinal follow-up before the diagnosis of diabetes have better glycaemic control, measured by HbA(1c), up to 5 years after diagnosis and during the initial period of partial remission. Improved glycaemic control in the initial years of living with type 1 diabetes could affect long-term outcome and complications and might also improve study enrolment in future longitudinal studies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00125-018-4706-z) contains peer-reviewed but unedited supplementary material, which is available to authorised users. Springer Berlin Heidelberg 2018-08-14 2019 /pmc/articles/PMC6290658/ /pubmed/30109365 http://dx.doi.org/10.1007/s00125-018-4706-z Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Short Communication Lundgren, Markus Jonsdottir, Berglind Elding Larsson, Helena Effect of screening for type 1 diabetes on early metabolic control: the DiPiS study |
title | Effect of screening for type 1 diabetes on early metabolic control: the DiPiS study |
title_full | Effect of screening for type 1 diabetes on early metabolic control: the DiPiS study |
title_fullStr | Effect of screening for type 1 diabetes on early metabolic control: the DiPiS study |
title_full_unstemmed | Effect of screening for type 1 diabetes on early metabolic control: the DiPiS study |
title_short | Effect of screening for type 1 diabetes on early metabolic control: the DiPiS study |
title_sort | effect of screening for type 1 diabetes on early metabolic control: the dipis study |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290658/ https://www.ncbi.nlm.nih.gov/pubmed/30109365 http://dx.doi.org/10.1007/s00125-018-4706-z |
work_keys_str_mv | AT lundgrenmarkus effectofscreeningfortype1diabetesonearlymetaboliccontrolthedipisstudy AT jonsdottirberglind effectofscreeningfortype1diabetesonearlymetaboliccontrolthedipisstudy AT eldinglarssonhelena effectofscreeningfortype1diabetesonearlymetaboliccontrolthedipisstudy AT effectofscreeningfortype1diabetesonearlymetaboliccontrolthedipisstudy |